These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 23966292)

  • 1. EGFR-activating mutations correlate with a Fanconi anemia-like cellular phenotype that includes PARP inhibitor sensitivity.
    Pfäffle HN; Wang M; Gheorghiu L; Ferraiolo N; Greninger P; Borgmann K; Settleman J; Benes CH; Sequist LV; Zou L; Willers H
    Cancer Res; 2013 Oct; 73(20):6254-63. PubMed ID: 23966292
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection of impaired homologous recombination repair in NSCLC cells and tissues.
    Birkelbach M; Ferraiolo N; Gheorghiu L; Pfäffle HN; Daly B; Ebright MI; Spencer C; O'Hara C; Whetstine JR; Benes CH; Sequist LV; Zou L; Dahm-Daphi J; Kachnic LA; Willers H
    J Thorac Oncol; 2013 Mar; 8(3):279-86. PubMed ID: 23399959
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acquisition of Relative Interstrand Crosslinker Resistance and PARP Inhibitor Sensitivity in Fanconi Anemia Head and Neck Cancers.
    Lombardi AJ; Hoskins EE; Foglesong GD; Wikenheiser-Brokamp KA; Wiesmüller L; Hanenberg H; Andreassen PR; Jacobs AJ; Olson SB; Keeble WW; Hays LE; Wells SI
    Clin Cancer Res; 2015 Apr; 21(8):1962-72. PubMed ID: 25609062
    [TBL] [Abstract][Full Text] [Related]  

  • 4. KIAA1018/FAN1 nuclease protects cells against genomic instability induced by interstrand cross-linking agents.
    Yoshikiyo K; Kratz K; Hirota K; Nishihara K; Takata M; Kurumizaka H; Horimoto S; Takeda S; Jiricny J
    Proc Natl Acad Sci U S A; 2010 Dec; 107(50):21553-7. PubMed ID: 21115814
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhanced dependency of KRAS-mutant colorectal cancer cells on RAD51-dependent homologous recombination repair identified from genetic interactions in Saccharomyces cerevisiae.
    Kalimutho M; Bain AL; Mukherjee B; Nag P; Nanayakkara DM; Harten SK; Harris JL; Subramanian GN; Sinha D; Shirasawa S; Srihari S; Burma S; Khanna KK
    Mol Oncol; 2017 May; 11(5):470-490. PubMed ID: 28173629
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Werner syndrome helicase has a critical role in DNA damage responses in the absence of a functional fanconi anemia pathway.
    Aggarwal M; Banerjee T; Sommers JA; Iannascoli C; Pichierri P; Shoemaker RH; Brosh RM
    Cancer Res; 2013 Sep; 73(17):5497-507. PubMed ID: 23867477
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of the Nedd8 system sensitizes cells to DNA interstrand cross-linking agents.
    Kee Y; Huang M; Chang S; Moreau LA; Park E; Smith PG; D'Andrea AD
    Mol Cancer Res; 2012 Mar; 10(3):369-77. PubMed ID: 22219386
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Involvement of homologous recombination in the synergism between cisplatin and poly (ADP-ribose) polymerase inhibition.
    Sakogawa K; Aoki Y; Misumi K; Hamai Y; Emi M; Hihara J; Shi L; Kono K; Horikoshi Y; Sun J; Ikura T; Okada M; Tashiro S
    Cancer Sci; 2013 Dec; 104(12):1593-9. PubMed ID: 24033642
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Fanci knockout mouse model reveals common and distinct functions for FANCI and FANCD2.
    Dubois EL; Guitton-Sert L; Béliveau M; Parmar K; Chagraoui J; Vignard J; Pauty J; Caron MC; Coulombe Y; Buisson R; Jacquet K; Gamblin C; Gao Y; Laprise P; Lebel M; Sauvageau G; D d'Andrea A; Masson JY
    Nucleic Acids Res; 2019 Aug; 47(14):7532-7547. PubMed ID: 31219578
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proteasome function is required for DNA damage response and fanconi anemia pathway activation.
    Jacquemont C; Taniguchi T
    Cancer Res; 2007 Aug; 67(15):7395-405. PubMed ID: 17671210
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stabilization of mutant BRCA1 protein confers PARP inhibitor and platinum resistance.
    Johnson N; Johnson SF; Yao W; Li YC; Choi YE; Bernhardy AJ; Wang Y; Capelletti M; Sarosiek KA; Moreau LA; Chowdhury D; Wickramanayake A; Harrell MI; Liu JF; D'Andrea AD; Miron A; Swisher EM; Shapiro GI
    Proc Natl Acad Sci U S A; 2013 Oct; 110(42):17041-6. PubMed ID: 24085845
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Distinct roles of FANCO/RAD51C protein in DNA damage signaling and repair: implications for Fanconi anemia and breast cancer susceptibility.
    Somyajit K; Subramanya S; Nagaraju G
    J Biol Chem; 2012 Jan; 287(5):3366-80. PubMed ID: 22167183
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reduced proficiency in homologous recombination underlies the high sensitivity of embryonal carcinoma testicular germ cell tumors to Cisplatin and poly (adp-ribose) polymerase inhibition.
    Cavallo F; Graziani G; Antinozzi C; Feldman DR; Houldsworth J; Bosl GJ; Chaganti RS; Moynahan ME; Jasin M; Barchi M
    PLoS One; 2012; 7(12):e51563. PubMed ID: 23251575
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preventing over-resection by DNA2 helicase/nuclease suppresses repair defects in Fanconi anemia cells.
    Karanja KK; Lee EH; Hendrickson EA; Campbell JL
    Cell Cycle; 2014; 13(10):1540-50. PubMed ID: 24626199
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differences in Expression of Key DNA Damage Repair Genes after Epigenetic-Induced BRCAness Dictate Synthetic Lethality with PARP1 Inhibition.
    Wiegmans AP; Yap PY; Ward A; Lim YC; Khanna KK
    Mol Cancer Ther; 2015 Oct; 14(10):2321-31. PubMed ID: 26294743
    [TBL] [Abstract][Full Text] [Related]  

  • 16. FANCD2-controlled chromatin access of the Fanconi-associated nuclease FAN1 is crucial for the recovery of stalled replication forks.
    Chaudhury I; Stroik DR; Sobeck A
    Mol Cell Biol; 2014 Nov; 34(21):3939-54. PubMed ID: 25135477
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessment of FANCD2 nuclear foci formation in paraffin-embedded tumors: a potential patient-enrichment strategy for treatment with DNA interstrand crosslinking agents.
    Duan W; Gao L; Zhao W; Leon M; Sadee W; Webb A; Resnick K; Wu X; Ramaswamy B; Cohn DE; Shapiro C; Andreassen PR; Otterson GA; Villalona-Calero MA
    Transl Res; 2013 Mar; 161(3):156-64. PubMed ID: 23063585
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ubiquitinated Fancd2 recruits Fan1 to stalled replication forks to prevent genome instability.
    Lachaud C; Moreno A; Marchesi F; Toth R; Blow JJ; Rouse J
    Science; 2016 Feb; 351(6275):846-9. PubMed ID: 26797144
    [TBL] [Abstract][Full Text] [Related]  

  • 19. FAN1 acts with FANCI-FANCD2 to promote DNA interstrand cross-link repair.
    Liu T; Ghosal G; Yuan J; Chen J; Huang J
    Science; 2010 Aug; 329(5992):693-6. PubMed ID: 20671156
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synergistic effect of olaparib with combination of cisplatin on PTEN-deficient lung cancer cells.
    Minami D; Takigawa N; Takeda H; Takata M; Ochi N; Ichihara E; Hisamoto A; Hotta K; Tanimoto M; Kiura K
    Mol Cancer Res; 2013 Feb; 11(2):140-8. PubMed ID: 23239809
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.